English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  Previous studies have shown a lower incidence of stroke in Parkinson’s disease (PD) patients. The role of the lipids and lipoproteins as risk factors for stroke is uncertain in the lower prevalence of stroke in PD patients.    Objectives  To explore the lipids and lipoproteins serum levels in PD patients.    Methods  A retrospective study was performed on 110 PD patients (PD group), 130 controls with non-cerebrovascular neurological diseases (OD group), 140 acute intracerebral hemorrhage patients (ICH group) and 140 acute cerebral infarction patients (CI group). The records about serum levels of lipids and lipoproteins were analyzed.    Results  There were significant differences for the serum level of triglyceride (F = 5.031,  p =0.002), very low density lipoprotein cholesterol (F = 5.313,  p =0.001), apolipoprotein B (F = 16.038,  p <0.0001) in the four groups. PD group had a significantly lower serum level of triglyceride (TG) than the OD ( p =0.032), ICH ( p =0.00047) and CI ( p =0.001) groups. Very low density lipoprotein cholesterol (VLDL-C) serum level was significantly lower in PD group than in OD ( p =0.039), ICH ( p =0.00021) and CI ( p =0.001) groups. There was a significantly lower serum level of apolipoprotein B (apo B) in PD group than in OD ( p =0.002), ICH ( p <0.0001) and CI ( p <0.0001) groups.    Conclusions  There are reduced serum levels of TG, VLDL-C and apo B in PD patients, which may be related to the decreased prevalence of stroke in PD patients.

Reduced Serum Levels of Triglyceride, Very Low Density Lipoprotein Cholesterol and Apolipoprotein B in Parkinson’s Disease Patients